ANI Pharmaceuticals, Inc.ANIPNASDAQ
Loading
Year-over-year debt growth rate
Latest
0.79%
↓ 82% vs avg
Percentile
P67
Within normal range
Streak
1 qtr
Consecutive growthRecovering
Average
4.50%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 0.79% |
| Q3 2025 | -48.09% |
| Q2 2025 | -0.20% |
| Q1 2025 | -0.20% |
| Q4 2024 | -0.20% |
| Q3 2024 | 119.24% |
| Q2 2024 | -0.07% |
| Q1 2024 | -0.07% |
| Q4 2023 | -0.07% |
| Q3 2023 | -0.07% |
| Q2 2023 | -0.07% |
| Q1 2023 | -0.07% |
| Q4 2022 | -0.07% |
| Q3 2022 | -0.07% |
| Q2 2022 | -0.07% |
| Q1 2022 | -0.07% |
| Q4 2021 | 42.27% |
| Q3 2021 | -1.33% |
| Q2 2021 | 11.60% |
| Q1 2021 | -1.22% |
| Q4 2020 | -1.20% |
| Q3 2020 | -1.19% |
| Q2 2020 | -4.88% |
| Q1 2020 | 7.65% |
| Q4 2019 | -0.46% |
| Q3 2019 | 0.49% |
| Q2 2019 | 0.98% |
| Q1 2019 | 0.48% |
| Q4 2018 | -11.06% |
| Q3 2018 | 0.57% |
| Q2 2018 | 1.03% |
| Q1 2018 | 0.51% |
| Q4 2017 | 33.20% |
| Q3 2017 | -2.01% |
| Q2 2017 | 1.23% |
| Q1 2017 | 26.41% |
| Q4 2016 | 1.54% |
| Q3 2016 | 1.55% |
| Q2 2016 | 1.56% |
| Q1 2016 | 1.56% |